Queshi Zhiji No. 2 Private Securities Investment Fund, managed by Hangzhou Queshi Private Equity Fund Management Co., Ltd. signed share transfer agreement to acquire 5.6% stake in Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHSE:600613) from Guizhou Shenqi Holdings (Group) Co., Ltd. for CNY 190 million on March 21, 2024.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
Equities
600613
CNE000000453
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.79 CNY | +0.74% | +3.98% | -10.78% |
1st Jan change | Capi. | |
---|---|---|
-10.78% | 482M | |
+33.21% | 700B | |
-4.96% | 358B | |
+18.87% | 330B | |
+3.50% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+5.47% | 161B | |
-2.26% | 157B |
- Stock Market
- Equities
- 600613 Stock
- News Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
- Queshi Zhiji No. 2 Private Securities Investment Fund, managed by Hangzhou Queshi Private Equity Fund Management Co., Ltd. signed share transfer agreement to acquire 5.6% stake in Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. from Guizhou Shenqi Holdings Co., Ltd. for CNY 190 million.